Pharmesis International Ltd. (SGX:BFK)
0.0840
0.00 (0.00%)
Nov 17, 2026, 4:09 PM SGT
Pharmesis International Revenue
Pharmesis International had revenue of 11.87M CNY in the half year ending June 30, 2026, a decrease of -50.30%. This brings the company's total for the last twelve months to 28.42M, down -59.97% year-over-year. In the year 2025, Pharmesis International had annual revenue of 43.75M, down -35.32%. That makes Pharmesis International the 40,585th largest company in the world by revenue and 488th in Singapore.
Revenue (ttm)
28.42M CNY
Revenue Growth
-59.97%
P/S Ratio
0.49
Revenue / Employee
25.93K CNY
Employees
1,096
Market Cap
2.66M SGD
Revenue by Segment
- Distribution 26.54M 38.5%
- TCM Formulated Drugs/IP Rental 26.05M 37.7%
- Western Drugs / TCH Procurement 16.43M 23.8%
Fiscal year ended Dec 31, 2025 See the full Pharmesis International breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.75M | -23.90M | -35.32% |
| Dec 31, 2024 | 67.65M | 22.01M | 48.24% |
| Dec 31, 2023 | 45.64M | -4.73M | -9.40% |
| Dec 31, 2022 | 50.37M | -2.40M | -4.55% |
| Dec 31, 2021 | 52.77M | 5.66M | 12.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Raffles Medical Group | 740.31M |
| Thomson Medical Group | 426.59M |
| Riverstone Holdings | 310.27M |
| Foundation Healthcare Holdings | 253.12M |
| Haw Par Corporation | 219.55M |
| Q & M Dental Group (Singapore) | 208.31M |
| Vicplas International | 131.25M |
| Cordlife Group | 34.64M |
Pharmesis International News
- 3 months ago - Pharmesis International Quarterly report: H1 2026 - Filings
- 8 months ago - Pharmesis International Annual report: H2 2025 - Filings
- 8 months ago - Pharmesis International Annual report: H2 2025 - Filings